Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain

doi:10.1084/jem.178.1.361

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Hwu, P.
	Articles by Eshhar, Z.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Hwu, P.
	Articles by Eshhar, Z.


Social Bookmarking

	What's this?

ARTICLES

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain

P Hwu, GE Shafer, J Treisman, DG Schindler, G Gross, R Cowherd, SA Rosenberg and Z Eshhar
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

To expand the spectrum of recognition of effector lymphocytes and to redirect them towards predefined targets, we have altered the specificity of human tumor-infiltrating lymphocytes (TIL) through stable modification with chimeric receptor genes consisting of single- chain antibody variable regions linked to the gamma subunit common to the immunoglobulin (Ig)G and IgE Fc receptors. Using either hapten or ovarian carcinoma-specific monoclonal antibodies, we constructed chimeric receptor genes and retrovirally introduced them into CD8+ TIL. Redirected TIL specifically lysed trinitrophenyl-labeled Daudi or a human ovarian carcinoma cell line (IGROV-1), and secreted granulocyte/macrophage colony-stimulating factor upon stimulation with the appropriate antigen. This strategy may allow new approaches towards the adoptive immunotherapy of cancer in humans.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Dobrenkov, K., Olszewska, M., Likar, Y., Shenker, L., Gunset, G., Cai, S., Pillarsetty, N., Hricak, H., Sadelain, M., Ponomarev, V. (2008). Monitoring the Efficacy of Adoptively Transferred Prostate Cancer-Targeted Human T Lymphocytes with PET and Bioluminescence Imaging. JNM 49: 1162-1170 [Abstract] [Full Text]
Kowolik, C. M., Topp, M. S., Gonzalez, S., Pfeiffer, T., Olivares, S., Gonzalez, N., Smith, D. D., Forman, S. J., Jensen, M. C., Cooper, L. J.N. (2006). CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells.. Cancer Res. 66: 10995-11004 [Abstract] [Full Text]
Kershaw, M. H., Westwood, J. A., Parker, L. L., Wang, G., Eshhar, Z., Mavroukakis, S. A., White, D. E., Wunderlich, J. R., Canevari, S., Rogers-Freezer, L., Chen, C. C., Yang, J. C., Rosenberg, S. A., Hwu, P. (2006). A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.. Clin. Cancer Res. 12: 6106-6115 [Abstract] [Full Text]
Zhang, T., Barber, A., Sentman, C. L. (2006). Generation of Antitumor Responses by Genetic Modification of Primary Human T Cells with a Chimeric NKG2D Receptor. Cancer Res. 66: 5927-5933 [Abstract] [Full Text]
Kershaw, M. H., Jackson, J. T., Haynes, N. M., Teng, M. W. L., Moeller, M., Hayakawa, Y., Street, S. E., Cameron, R., Tanner, J. E., Trapani, J. A., Smyth, M. J., Darcy, P. K. (2004). Gene-Engineered T Cells as a Superior Adjuvant Therapy for Metastatic Cancer. J. Immunol. 173: 2143-2150 [Abstract] [Full Text]
McFarland, H. I., Hansal, S. A., Morris, D. I., McVicar, D. W., Love, P. E., Rosenberg, A. S. (2003). Signaling through MHC in transgenic mice generates a population of memory phenotype cytolytic cells that lack TCR. Blood 101: 4520-4528 [Abstract] [Full Text]
Pinthus, J. H., Waks, T., Kaufman-Francis, K., Schindler, D. G., Harmelin, A., Kanety, H., Ramon, J., Eshhar, Z. (2003). Immuno-Gene Therapy of Established Prostate Tumors Using Chimeric Receptor-redirected Human Lymphocytes. Cancer Res. 63: 2470-2476 [Abstract] [Full Text]
Haynes, N. M., Trapani, J. A., Teng, M. W. L., Jackson, J. T., Cerruti, L., Jane, S. M., Kershaw, M. H., Smyth, M. J., Darcy, P. K. (2002). Rejection of Syngeneic Colon Carcinoma by CTLs Expressing Single-Chain Antibody Receptors Codelivering CD28 Costimulation. J. Immunol. 169: 5780-5786 [Abstract] [Full Text]
Haynes, N. M., Trapani, J. A., Teng, M. W. L., Jackson, J. T., Cerruti, L., Jane, S. M., Kershaw, M. H., Smyth, M. J., Darcy, P. K. (2002). Single-chain antigen recognition receptors that costimulate potent rejection of established experimental tumors. Blood 100: 3155-3163 [Abstract] [Full Text]
Haynes, N. M., Snook, M. B., Trapani, J. A., Cerruti, L., Jane, S. M., Smyth, M. J., Darcy, P. K. (2001). Redirecting Mouse CTL Against Colon Carcinoma: Superior Signaling Efficacy of Single-Chain Variable Domain Chimeras Containing TCR-{{zeta}} vs Fc{{epsilon}}RI-{{gamma}}. J. Immunol. 166: 182-187 [Abstract] [Full Text]
Brocker, T. (2000). Chimeric Fv-zeta or Fv-epsilon receptors are not sufficient to induce activation or cytokine production in peripheral T cells. Blood 96: 1999-2001 [Abstract] [Full Text]
Guttinger, M., Guidi, F., Chinol, M., Reali, E., Veglia, F., Viale, G., Paganelli, G., Corti, A., Siccardi, A. G. (2000). Adoptive Immunotherapy by Avidin-driven Cytotoxic T Lymphocyte- Tumor Bridging. Cancer Res. 60: 4211-4215 [Abstract] [Full Text]
Dardalhon, V., Jaleco, S., Rebouissou, C., Ferrand, C., Skander, N., Swainson, L., Tiberghien, P., Spits, H., Noraz, N., Taylor, N. (2000). Highly efficient gene transfer in naive human T cells with a murine leukemia virus-based vector. Blood 96: 885-893 [Abstract] [Full Text]
Darcy, P. K., Haynes, N. M., Snook, M. B., Trapani, J. A., Cerruti, L., Jane, S. M., Smyth, M. J. (2000). Redirected Perforin-Dependent Lysis of Colon Carcinoma by Ex Vivo Genetically Engineered CTL. J. Immunol. 164: 3705-3712 [Abstract] [Full Text]
Nolan, K. F., Yun, C.-O., Akamatsu, Y., Murphy, J. C., Leung, S.-O., Beecham, E. J., Junghans, R. P. (1999). Bypassing Immunization: Optimized Design of ""Designer T Cells"" against Carcinoembryonic Antigen (CEA)-expressing Tumors, and Lack of Suppression by Soluble CEA. Clin. Cancer Res. 5: 3928-3941 [Abstract] [Full Text]
Steele, J. C., Young, S. P., Goodall, J. C., Gallimore, P. H. (1998). Structural Aspects of the Interaction Between Heterogeneic Human Papillomavirus Type 1 E4-Specific T Cell Receptors and the Same Peptide/HLA-DQ8 Complex. J. Immunol. 161: 4745-4752 [Abstract] [Full Text]
Finney, H. M., Lawson, A. D. G., Bebbington, C. R., Weir, A. N. C. (1998). Chimeric Receptors Providing Both Primary and Costimulatory Signaling in T Cells from a Single Gene Product. J. Immunol. 161: 2791-2797 [Abstract] [Full Text]
Fields, R. C., Shimizu, K., Mule, J. J. (1998). Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 9482-9487 [Abstract] [Full Text]
Roberts, M. R., Cooke, K. S., Tran, A.-C., Smith, K. A., Lin, W. Y., Wang, M., Dull, T. J., Farson, D., Zsebo, K. M., Finer, M. H. (1998). Antigen-Specific Cytolysis by Neutrophils and NK Cells Expressing Chimeric Immune Receptors Bearing {zeta} or {gamma} Signaling Domains. J. Immunol. 161: 375-384 [Abstract] [Full Text]
Fitzer-Attas, C. J., Schindler, D. G., Waks, T., Eshhar, Z. (1998). Harnessing Syk Family Tyrosine Kinases as Signaling Domains for Chimeric Single Chain of the Variable Domain Receptors: Optimal Design for T Cell Activation. J. Immunol. 160: 145-154 [Abstract] [Full Text]
Hege, K. M., Cooke, K. S., Finer, M. H., Zsebo, K. M., Roberts, M. R. (1996). Systemic T Cell-independent Tumor Immunity after Transplantation of Universal Receptor-modified Bone Marrow into SCID Mice. J. Exp. Med. 184: 2261-2270 [Abstract] [Full Text]
Kershaw, M. H., Darcy, P. K., Hulett, M. D., Hogarth, P. M., Trapani, J. A., Smyth, M. J. (1996). Redirected Cytotoxic Effector Function. REQUIREMENTS FOR EXPRESSION OF CHIMERIC SINGLE CHAIN HIGH AFFINITY IMMUNOGLOBULIN E RECEPTORS. J. Biol. Chem. 271: 21214-21220 [Abstract] [Full Text]